The vestibular symptomatology of Machado-Joseph Disease

被引:0
|
作者
Elyoseph, Zohar [1 ,2 ,3 ]
Geisinger, Dario [4 ]
Zaltzman, Roy [3 ,5 ]
Mintz, Matti [1 ,6 ,7 ]
Gordond, Carlos R. [4 ,5 ,6 ]
机构
[1] Tel Aviv Univ, Sch Psychol Sci, Tel Aviv, Israel
[2] Max Stern Yezreel Valley Coll, Ctr Psychobiol Res, Dept Psychol & Educ Counseling, Jezreel Valley, Israel
[3] Imperial Coll London, Dept Brain Sci, Fac Med, London, England
[4] Tel Aviv Univ, Fac Med, Tel Aviv, Israel
[5] Meir Med Ctr, Dept Neurol, IL-44281 Kefar Sava, Israel
[6] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[7] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel
来源
JOURNAL OF VESTIBULAR RESEARCH-EQUILIBRIUM & ORIENTATION | 2024年 / 34卷 / 2-3期
关键词
Cerebellum; Machado-Joseph Disease; Spinocerebellar Ataxia type 3; Vestibular; Dizziness Handicap Inventory; Bilateral Vestibulopathy; SPINOCEREBELLAR ATAXIA TYPE-3; VESTIBULOOCULAR REFLEX VOR; HEAD IMPULSE TEST; ANXIETY; REHABILITATION; CLASSIFICATION; PERFORMANCE;
D O I
10.3233/VES-230038
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Machado Joseph Disease (MJD) is an autosomal dominant neurodegenerative disease. In previous studies, we described significant bilateral horizontal Vestibulo-Ocular Reflex (VOR) deficit within this population without any reference to the presence of vestibular symptomatology. OBJECTIVE: To evaluate whether, beyond cerebellar ataxia complaints, MJD patients have typical vestibular symptomatology corresponding to the accepted diagnostic criteria of Bilateral Vestibulopathy (BVP) according to the definition of the International Barany Society of Neuro-Otology. METHODS: Twenty-one MJD, 12 clinically stable chronic Unilateral Vestibulopathy (UVP), 15 clinically stable chronic BVP, and 22 healthy Controls underwent the video Head Impulse Test (vHIT) evaluating VOR gain and filled out the following questionnaires related to vestibular symptomatology: The Dizziness Handicap Inventory (DHI), the Activitiesspecific Balance Confidence Scale (ABC), the Vertigo Visual Scale (VVS) and the Beck Anxiety Inventory (BAI). RESULTS: The MJD group demonstrated significant bilateral vestibular impairment with horizontal gain less than 0.6 in 71% of patients (0.54 +/- 0.17). Similar to UVP and BVP, MJD patients reported a significantly higher level of symptoms than Controls in the DHI, ABC, VVS, and BAI questionnaires. CONCLUSIONS: MJD demonstrated significant VOR impairment and clinical symptoms typical of BVP. We suggest that in a future version of the International Classification of Vestibular Disorders (ICVD), MJD should be categorized under a separate section of central vestibulopathy with the heading of bilateral vestibulopathy. The present findings are of importance regarding the clinical diagnosis process and possible treatment based on vestibular rehabilitation.
引用
收藏
页码:159 / 167
页数:9
相关论文
共 50 条
  • [41] Trehalose alleviates the phenotype of Machado-Joseph disease mouse models
    Santana, Magda M.
    Paixao, Susana
    Cunha-Santos, Janete
    Silva, Teresa Pereira
    Trevino-Garcia, Allyson
    Gaspar, Laetitia S.
    Nobrega, Clevio
    Nobre, Rui Jorge
    Cavadas, Claudia
    Greif, Hagar
    de Almeida, Luis Pereira
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
  • [42] Beneficial effects of tandospirone on ataxia of a patient with Machado-Joseph disease
    Takei, A
    Honma, S
    Kawashima, A
    Yabe, I
    Fukazawa, T
    Hamada, K
    Hamada, T
    Tashiro, K
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2002, 56 (02) : 181 - 185
  • [43] Serum melatonin levels and insomnia in patients with Machado-Joseph Disease
    Takei A.
    Fukazawa T.
    Hamada T.
    Sohma H.
    Yabe I.
    Sasaki H.
    Okawa M.
    Sleep and Biological Rhythms, 2004, 2 (3) : 209 - 214
  • [44] Sleep apnea in Machado-Joseph disease: a clinical and polysomnographic evaluation
    Folha Santos, Felipe Augusto
    de Carvalho, Luciane Bizari C.
    do Prado, Lucila Fernandes
    do Prado, Gilmar Fernandes
    Barsottini, Orlando G.
    Pedroso, Jose Luiz
    SLEEP MEDICINE, 2018, 48 : 23 - 26
  • [45] Urinary symptoms and urodynamic findings in patients with Machado-Joseph disease
    Musegante, Andre F. A.
    Almeida, Priscila N. S.
    Barboza, Andre L.
    Barroso, Ubirajara, Jr.
    JOURNAL OF NEUROLOGY, 2011, 258 (04) : 623 - 626
  • [46] DISCREDITED INHERITANCE - MACHADO-JOSEPH DISEASE AND FAMILY DYNAMICS IN THE AZORES
    BOUTTE, MI
    HUMAN ORGANIZATION, 1992, 51 (02) : 144 - 150
  • [47] Clinical manifestations and gene mutation in a case of Machado-Joseph disease
    Zhang, Bin
    Li, Liru
    Chen, Longxing
    Huang, Jie
    NEURAL REGENERATION RESEARCH, 2012, 7 (35) : 2842 - 2847
  • [48] Analysis of CAG trinucleotide expansion associated with Machado-Joseph disease
    Watanabe, M
    Abe, K
    Aoki, M
    Kameya, T
    Kaneko, J
    Shoji, M
    Ikeda, M
    Shizuka, M
    Ikeda, Y
    Iizuka, T
    Hirai, S
    Itoyama, Y
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 136 (1-2) : 101 - 107
  • [49] Clinical correlates of autonomic dysfunction in patients with Machado-Joseph disease
    Franca, M. C., Jr.
    D'Abreu, A.
    Nucci, A.
    Lopes-Cendes, I.
    ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (06): : 422 - 425
  • [50] The Neuropathology of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
    Koeppen, Arnulf H.
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 233 - 241